Over recent years, the occurrence of hospital infections caused by methicillin resistant Staphylococcus aureus (MRSA) has been increasing steadily, representing around 20 to 55% of the isolates in Europe and in the USA. Leading cause of nosocomial infections, especially in intensive care units, the MRSA sources are either endogenous (the patient) or through cross contamination (environmental or by person to person contact). The major issue with this pathogen is its resistance to a large panel of antibiotics, among them beta-lactam antibiotics, limiting the therapeutic options for clinicians.
InTray COLOREX MRSA provides an easy-to-use, in-house, chromogenic result for surface testing and AMR surveillance.
|Time to Result|
87040 | 87070 | 87081 | 87088 | 87075 | 87086
Isaac See, Yi Mu, Valerie Albrecht, Maria Karlsson, Ghinwa Dumyati, Dwight J Hardy, Mackenzie Koeck, Ruth Lynfield, Joelle Nadle, Susan M Ray, William Schaffner, Alexander J Kallen; Trends in incidence of methicillin-resistant Staphylococcus aureus bloodstream infections differ by strain type and healthcare exposure,
United States, 2005–2013, Clinical Infectious Diseases, , ciz158,